- USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway
Jing Cai et al, 2017, Biochemical and Biophysical Research Communications CrossRef - The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay
Maghawry Hegazy et al, 2023, Pathology - Research and Practice CrossRef - Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem
Michela Falco et al, 2022, Cancers CrossRef - Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs
Ian Henry Lambert et al, 2018, International Journal of Molecular Sciences CrossRef - Non-coding RNAs in drug resistance of head and neck cancers: A review
Fengsheng Dai et al, 2020, Biomedicine & Pharmacotherapy CrossRef - MiR-133a-3p overexpression-induced elevation of cisplatin-mediated chemosensitivity to non-small cell lung cancer by targeting replication factor C3
Guanqun Dai et al, 2021, Process Biochemistry CrossRef - miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses
Hesham A. El-Mahdy et al, 2023, Pathology - Research and Practice CrossRef - miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
Yang Zhou et al, 2022, Cancer Cell International CrossRef - LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway
Li Xu et al, 2020, BMC Pulmonary Medicine CrossRef - Astragalus Polysaccharide Suppresses Cell Proliferation and Invasion by Up-Regulation of miR-195-5p in Non-small Cell Lung Cancer
Xingkui Tao et al, 2022, Biological and Pharmaceutical Bulletin CrossRef - The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Jiabei Zhou et al, 2020, Frontiers in Pharmacology CrossRef - MiR‐133a‐3p attenuates resistance of non‐small cell lung cancer cells to gefitinib by targeting SPAG5
Qing Li et al, 2021, Journal of Clinical Laboratory Analysis CrossRef - Peculiarities of interaction of malignant cells and tumors with chemotherapeutic nanocomposite remedies
null null et al, 2023, Surface CrossRef